✉news TechnologyAI first seen 15 h ago, last 10 h ago, peak #6
AI Adoption in Clinical Trials Held Back by Governance Gaps
Original: AI Adoption in Clinical Trials Hindered by Validation, Governance Gaps
Artificial intelligence is being adopted only slowly in clinical trials, with validation and governance gaps cited as the main obstacles. Industry commentary says sponsors and regulators still lack agreed standards for verifying AI tools before they are used in trial design, patient selection or data analysis, leaving many organisations cautious despite the technology's potential to speed up drug development.
Why now: Ongoing industry debate about how to safely regulate and validate AI in medical research.
clinical trialsartificial intelligencepharmaceutical industry
Evidence
- AI Adoption in Clinical Trials Hindered by Validation, Governance Gaps · The Clinical Trial Vanguard
API: https://socialmediatrends-api.osmike.com/v1/trends/1955185